66 related articles for article (PubMed ID: 15347907)
1. Surveillance for hospitalizations with infection-related diagnoses after chemotherapy among breast cancer patients diagnosed before age 65.
Polednak AP
Chemotherapy; 2004 Oct; 50(4):157-61. PubMed ID: 15347907
[TBL] [Abstract][Full Text] [Related]
2. Risk of dementia in older breast cancer survivors: a population-based cohort study of the association with adjuvant chemotherapy.
Baxter NN; Durham SB; Phillips KA; Habermann EB; Virning BA
J Am Geriatr Soc; 2009 Mar; 57(3):403-11. PubMed ID: 19278395
[TBL] [Abstract][Full Text] [Related]
3. Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer.
Hassett MJ; O'Malley AJ; Pakes JR; Newhouse JP; Earle CC
J Natl Cancer Inst; 2006 Aug; 98(16):1108-17. PubMed ID: 16912263
[TBL] [Abstract][Full Text] [Related]
4. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
[TBL] [Abstract][Full Text] [Related]
5. Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate-grade non-Hodgkin lymphoma.
Lyman GH; Delgado DJ
Cancer; 2003 Dec; 98(11):2402-9. PubMed ID: 14635075
[TBL] [Abstract][Full Text] [Related]
6. Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987-2000.
Harlan LC; Clegg LX; Abrams J; Stevens JL; Ballard-Barbash R
J Clin Oncol; 2006 Feb; 24(6):872-7. PubMed ID: 16484696
[TBL] [Abstract][Full Text] [Related]
7. [Correlation of fever to infection in patients with chemotherapy-induced neutropenia].
Ruan YP; Zhang WY
Ai Zheng; 2008 Aug; 27(8):879-81. PubMed ID: 18710626
[TBL] [Abstract][Full Text] [Related]
8. Risk of hospitalization for neutropenic complications of chemotherapy in patients with primary solid tumors receiving pegfilgrastim or filgrastim prophylaxis: a retrospective cohort study.
Weycker D; Malin J; Kim J; Barron R; Edelsberg J; Kartashov A; Oster G
Clin Ther; 2009 May; 31(5):1069-81. PubMed ID: 19539108
[TBL] [Abstract][Full Text] [Related]
9. Targeted filgrastim support in patients with early-stage breast carcinoma: toward the implementation of a risk model.
Rivera E; Erder MH; Moore TD; Shiftan TL; Knight CA; Fridman M; Brannan C; Danel-Moore L; Hortobagyi GN;
Cancer; 2003 Jul; 98(2):222-8. PubMed ID: 12872339
[TBL] [Abstract][Full Text] [Related]
10. Incidence, cost, and mortality of neutropenia hospitalization associated with chemotherapy.
Caggiano V; Weiss RV; Rickert TS; Linde-Zwirble WT
Cancer; 2005 May; 103(9):1916-24. PubMed ID: 15751024
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy of nonelderly breast cancer patients by poverty-rate of area of residence in Connecticut.
Polednak AP
Breast Cancer Res Treat; 2004 Feb; 83(3):245-8. PubMed ID: 14758094
[TBL] [Abstract][Full Text] [Related]
12. Estimating breast cancer treatment charges in Connecticut.
Polednak AP; Shevchenko IP; Flannery JT
Conn Med; 1996 May; 60(5):263-7. PubMed ID: 8998905
[TBL] [Abstract][Full Text] [Related]
13. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
Mariotto AB; Feuer EJ; Harlan LC; Abrams J
J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
[TBL] [Abstract][Full Text] [Related]
14. Clinical and economic outcomes associated with adjuvant chemotherapy in elderly patients with early stage operable breast cancer.
Sail KR; Franzini L; Lairson DR; Du XL
Value Health; 2012 Jan; 15(1):72-80. PubMed ID: 22264974
[TBL] [Abstract][Full Text] [Related]
15. Patterns of dementia diagnosis in surveillance, epidemiology, and end results breast cancer survivors who use chemotherapy.
Heck JE; Albert SM; Franco R; Gorin SS
J Am Geriatr Soc; 2008 Sep; 56(9):1687-92. PubMed ID: 18691280
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study.
Doyle JJ; Neugut AI; Jacobson JS; Grann VR; Hershman DL
J Clin Oncol; 2005 Dec; 23(34):8597-605. PubMed ID: 16314622
[TBL] [Abstract][Full Text] [Related]
17. Identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection.
Ammann RA; Hirt A; Lüthy AR; Aebi C
Med Pediatr Oncol; 2003 Nov; 41(5):436-43. PubMed ID: 14515382
[TBL] [Abstract][Full Text] [Related]
18. Comparison of hospitalization risk and associated costs among patients receiving sargramostim, filgrastim, and pegfilgrastim for chemotherapy-induced neutropenia.
Heaney ML; Toy EL; Vekeman F; Laliberté F; Dority BL; Perlman D; Barghout V; Duh MS
Cancer; 2009 Oct; 115(20):4839-48. PubMed ID: 19637341
[TBL] [Abstract][Full Text] [Related]
19. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
[TBL] [Abstract][Full Text] [Related]
20. Predicting bacteremia in children with fever and chemotherapy-induced neutropenia.
Ammann RA; Hirt A; Lüthy AR; Aebi C
Pediatr Infect Dis J; 2004 Jan; 23(1):61-7. PubMed ID: 14743049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]